Endocrinologie et syndrome métabolique
Libre accès

Abstrait

Pharmacological Options in Cushing's Syndrome

Duran-Perez Edgar Gerardo, Moreno-Loza Oscar Tarcicio, Segovia-Palomo Antonio, Chavira-Lopez Ismael Javier, Carrasco-Tobon German and Lujano Nicolas Leslye Asela

The endogenous Cushing’s syndrome is a pathology which represents a diagnostic and therapeutic challenge for the specialist. Even though surgery is the first-line treatment, it is common to resort to pharmacological therapy in the preoperative setting because of the clinical instability or because the purpose is improving the medical condition of the patient before the surgery. Furthermore, because of the low successful rates with the surgical approach, the adjuvant pharmacological treatment ranks the first place because its purpose is to improve the possibilities of disease remission. This review deals with the current pharmacological therapies for the management of endogenous Cushing’s syndrome.